Aandeel 300511 SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Shanghai Xuerong Biotechnology Co.,Ltd.

Aandelen

300511

CNE100002706

slotkoers Shenzhen S.E.
Andere beurzen
 00:00:00 29-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
3,59 CNY +4,06% Intraday-grafiek van Shanghai Xuerong Biotechnology Co.,Ltd. +13,25% -32,90%
25/04 Shanghai Xuerong Biotechnology Co.,Ltd. rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024 CI
2023 Shanghai Xuerong Biotechnology Co. rapporteert winstresultaten voor de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Approves Board Appointments
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. Approves By-Election of Directors
Shanghai Xuerong Biotechnology Co.,Ltd. Announces Final Cash Dividend Proposal for 2021
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. announced that it has received CNY 397.999996 million in funding
Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity Investment & Management Co., Ltd. agreed to acquire 5% stake in Shanghai Xuerong Biotechnology Co.,Ltd. from Yang Yongping for CNY134 million.
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shanghai Xuerong Biotechnology Co.,Ltd. Announces to Implement Final Cash Distribution Plan for 2020, Payable on 14 May 2021
Shanghai Xuerong Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2020
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Shanghai Xuerong Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2020
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Shanghai Juhui Biopharmaceutical Industrial Development Co., Ltd. entered into a share transfer agreement to acquire Shanghai Gaorong Biotechnology Co., Ltd. from Shanghai Xuerong Biotechnology Co., Ltd. and Shanghai Xuerong Edible Fungus Co., Ltd for CNY 78 million.
Shanghai Xuerong Biotechnology Co., Ltd. announced that it expects to receive CNY 2.25 billion in funding
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 300511
  4. Nieuws Shanghai Xuerong Biotechnology Co.,Ltd.
  5. Andere talen